 NEW YORK, Dec. 22, 2020 GLOBE NEWSWIRE -- PAVmed Inc. Nasdaq: PAVM, PAVMZ the Company or PAVmed, a highly differentiated, multi-product, commercial-stage medical device company, today announced the closing of its previously announced registered direct offering the Offering of approximately 5.1 million shares of common stock at a price of 1.60 per share. 